Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole versus prednisone in persistent severe asthma
IRCT20181225042116N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma and severe asthma comparing Itraconazole arm with Prednisone arm (2 arms). Primary endpoints: Wheezing, FGF2 gene expression and 7 more. Started Dec 2020; status: completed.
02
Drugs
itraconazoleprednisone
03
Conditions
asthmasevere asthma
Beyond the preview
Go deeper on IRCT20181225042116N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181225042116N1.